GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Indo US Bio-Tech Ltd (NSE:INDOUS) » Definitions » Change In Payables And Accrued Expense

Indo US Bio-Tech (NSE:INDOUS) Change In Payables And Accrued Expense : ₹0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Indo US Bio-Tech Change In Payables And Accrued Expense?

Indo US Bio-Tech's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was ₹0.0 Mil. It means Indo US Bio-Tech's Accounts Payable & Accrued Expense stayed the same from Mar. 2024 to Sep. 2024 .

Indo US Bio-Tech's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2024 was ₹0.0 Mil. It means Indo US Bio-Tech's Accounts Payable & Accrued Expense stayed the same from Mar. 2023 to Mar. 2024 .

Indo US Bio-Tech Change In Payables And Accrued Expense Historical Data

The historical data trend for Indo US Bio-Tech's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo US Bio-Tech Change In Payables And Accrued Expense Chart

Indo US Bio-Tech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Indo US Bio-Tech Quarterly Data
Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Mar23 Sep23 Mar24 Sep24
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Indo US Bio-Tech Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo US Bio-Tech Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Indo US Bio-Tech's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Indo US Bio-Tech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Indo US Bio-Tech Ltd (NSE:INDOUS) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
Traded in Other Exchanges
541304:India
Address
Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061
Website
https://www.indousagriseeds.com
Indo US Bio-Tech Ltd is engaged in the trading of agricultural seeds. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of agriculture crops. The company's product categories include vegetables; cotton seeds; oilseeds; spices seeds; pulses seeds and cereals seeds. The company has two segments which include Agricultural Activities and Trading Activities out of which it generates the key revenue from the Agricultural Activities.

Indo US Bio-Tech Headlines

No Headlines